A B S T R A C T Evidence was obtained regarding the way the 02-forming NADPH oxidase of human neutrophils is arranged within the plasma membrane. 02 production by particles from zymosan-activated human neutrophils rose two-to threefold when the particles were assayed in the presence ofappropriate concentrations of Triton X-100. The portion of activity revealed by the detergent was not affected by treating the particles with trypsin or with p-chloromercuribenzene sulfonate, a nonpenetrating sulfhydryl reagent, but the activity detectable in the absence of detergent was abolished by these treatments. 0°production by phagocytic vesicles was not augmented by detergent, and was almost entirely eliminated by tryptic digestion of the vesicles regardless of whether or not detergent was present during the assay. These results suggest that the 02-forming oxidase is embedded in the plasma membrane with a portion extending into the cytoplasm and the rest buried in the lipid bilayer. It is proposed that the pyridine nucleotide-binding site is located on the cytoplasmic extension and the oxygen binding site is on the intramembranous portion of the enzyme. INTRODUCTION When a microorganism is ingested by a neutrophil, it becomes tightly enclosed within a vesicle whose wall consists of a portion of what was originally the plasma membrane of the phagocyte. Within this plasma membrane is an oxidase that catalyzes the one-electron reduction of oxygen to°2 at the expense of NADPH
INTRODUCTION
When a microorganism is ingested by a neutrophil, it becomes tightly enclosed within a vesicle whose wall consists of a portion of what was originally the plasma membrane of the phagocyte. Within this plasma membrane is an oxidase that catalyzes the one-electron reduction of oxygen to°2 at the expense of NADPH (1-6):
202+ NADPH --2 0°+ NADP. This oxidase is dormant in the resting cells, but when activated, as by the exposure of the neutrophil to an opsonized bacterium, it is responsible for the production of large quantities of°2 and other partially reduced oxygen derivatives that enter the phagocytic 1724 vesicle and participate in the destruction of the ingested microorganism (7) (8) (9) .
Experiments with cytochalasin B-paralyzed neutrophils have shown that all the oxygen consumed in the respiratory burst can be accounted for as°2 liberated into the external medium (10) . Quantitative recovery of°2 would be unlikely if the 0°were being first released into the cytoplasm, because under these circumstances the superoxide dismutase ofthe neutrophil (11) would almost certainly destroy at least part of the°2 before it could diffuse out through the plasma membrane. This finding therefore seems to indicate that the 02-forming reaction is taking place at the outer surface of the cell. The reducing agent, however, is a cytoplasmic constituent, and must donate its electrons to an acceptor no more remote from the cytoplasm than the inner face of the plasma membrane. Taken together, these observations suggest that the NADPH oxidase is a transmembrane enzyme, picking up an electron at the inner face of the membrane and transporting it through to an oxygen molecule at the outer face. It was to test this idea that the studies reported here were performed.
02-forming particles and phagosomes. These were obtained from human neutrophils prepared by dextran sedimentation and differential centrifugation (12) and suspended in 0.25 M sucrose adjusted to pH 7.4 with 0.1 M NaOH. O-forming particles were prepared from zymosan-activated neutrophils by sonication and centrifugation as described by Gabig and Babior (6) , and suspended in 0.25 M sucrose (pH 7.4) at 1.0 mg protein/ml.
O-forming phagosomes were prepared by a modification of the method of Segal et al. (13) . Latex particles were washed once with 0.9% NaCl, then incubated for 30 min at 25°C in 0.9% NaCl containing 50 ,lJ/ml stock PMA solution. The particles were then centrifuged and resuspended in HBSS to a final concentration of 4 x 1010 particles/ml, determined by measuring the turbidity of the suspension at 620 nm using the commercial particle suspension as standard. To 0.5 ml of the PMA-treated latex particles was added 0.02 ml of 0.1 M NaN3 followed by 1.5 ml neutrophil suspension (1.33 x 10" cells/ml). This mixture was incubated for 7 min at 37°C. The incubation was terminated by the addition of 15 ml of ice-cold HBSS. Cells were isolated by centrifugation at 125 g for 12 min at 40C, suspended in 5 ml of 11.2% sucrose (pH 7.4), and disrupted by hand homogenization (100 strokes) in a 10-ml Potter-Elvehjem homogenizer at 4°C. Solid DNAse, 4 mg, was added to the resulting homogenate, which was incubated at 0°C for 10 min. 12 ml ice-cold 60% (wt/vol) sucrose (pH 7.4) was then added, and the diluted homogenate was placed in a 1 x 3.5-in polyallomer centrifuge tube. The homogenate was successively overlaid with 15 ml of 33% (wt/vol) sucrose (pH 7.4) followed by 5 ml of 11.2% (wt/vol) sucrose (pH 7.4), then centrifuged in an SW 28 swinging bucket rotor at 24,000 g for 20 min at 4°C. Phagocytic vesicles accumulated at the interface between the two upper sucrose layers. The vesicles were carefully aspirated and diluted with distilled water to a final sucrose concentration of0.25 M, as determined with a Fisher refractometer (Fisher Scientific Co., Pitsburgh, Pa.).
Measurement of°2 production. O2 production was measured by a modification of a previously described method (14) . Reaction mixtures were prepared in a total volume of 2.0 ml, using 1.0 ml HBSS as buffer. The reaction was begun by adding particles or phagosomes. Immediately, 1.0 ml of reaction mixture was placed in a tube containing 10 Al superoxide dismutase (3 mg/ml) to serve as reference. The remainder was incubated at room temperature for the desired time in the dark. The incubation was stopped with 10 pJ superoxide dismutase, and O2 production was measured spectrophotometrically as dismutase-inhibitable cytochrome c reduction as described elsewhere. In assays of O2 production by phagosomes, the phagosomes were removed by centrifugation for 2 min in an Eppendorfmicrofuge prior to spectrometry. Protein concentration. Protein concentration was determined by the method of Bradford (15) .
Digestion with trypsin. Digestion with trypsin was conducted at 23°C. Into each of six tubes was placed 0.6 ml of particle suspension. The tubes were separated into pairs, one member of each pair receiving 0.1 ml 40 ,uM FAD plus 0.1 ml 0.25 M sucrose, and the other 0.1 ml FAD plus 0.1 ml 0.20% Triton X-100 in 0.25 M sucrose. Particles in one pair of tubes were digested by adding to each tube 0.1 ml freshly dissolved trypsin (10 mg/ml in 0.25 M sucrose) and incubating for 10 min. Digestion was stopped with 0.1 ml SBTI (15 mg/ml in 0.25 M sucrose), and the tubes were placed on ice. Each of a second pair of tubes was incubated for 10 min with 0.2 ml of a 1:1 mixture of trypsin and SBTI, then placed on ice. The other two tubes were received 0.2 ml 0.25 M sucrose, and were kept on ice throughout. Assays were then performed using 0.2-ml portions of each sample in the assay mixture.
Treatment of phagosomes with trypsin was carried out by a similar procedure, except that incubations were carried out for 3 min, and digestion was not carried out in the presence of Triton. Treatment with pCMBS. pCMBS was dissolved in water, brought to pH 7.4 with NaHCO3, and diluted to 1 mM to make up the stock solution. 02-forming particles were treated with this reagent by placing 0.9-ml portions of particle suspension in centrifuge tubes and mixing them first with pyridine nucleotides (where indicated), then with water or pCMBS to bring the final volumes to 1.0 ml and the final concentrations to those indicated in Results. Incubations were carried out for 2 min at 0°C, then terminated by the addition of 1.0 ml of 0.1 mM glutathione. Particles were then isolated by centrifugation at 25,000 g for 20 min at 4°C, washed once with 0.25 M sucrose (pH 7.4), and finally suspended in the same medium. Assays were performed using 0.2-ml portions of each sample as described below.
RESULTS
The superoxide-forming enzyme in neutrophil homogenates is found in vesicles of plasma membrane (4). In principle, such plasma membrane vesicles can consist of two populations: one in which the vesicle membrane is oriented as it was in the cell, with what was originally its outer surface facing the exterior (normal); and one in which its orientation is reversed, its inner or cytoplasmic surface facing the exterior (inverted). If in the neutrophil the oxidase is asymmetrically situated in the membrane, with its pyridine nucleotidebinding site in contact with the cytosol, then in the homogenate the pyridine nucleotide binding site will be facing the lumen in normal vesicles, but will be on the outer surface of inverted vesicles. Since NADPH, a large, charged molecule, is unlikely to penetrate into the lumen of the vesicles, only the oxidase activity of the inverted vesicles would be detectible under ordinary circumstances, assuming a vectorial orientation of the enzyme. Detection of the total oxidase activity would require the disruption of the vesicle structure. The oxidase should thus exhibit latency similar to that seen with lysosomal enzymes, the ratio of activities of intact and disrupted vesicles varying with the proportion of inverted vesicles in the total population.
This possibility was tested using Triton X-100 as the vesicle-disrupting agent. When O2 production by an active neutrophil homogenate was examined as a function of detergent concentration, an abrupt increase in activity was seen as the detergent reached its critical micellar concentration (16) (Fig. 1) . The cellfree oxidase thus exhibits latency, a finding consistent with the idea that the enzyme is vectorially arranged in the plasma membrane. The fact that the electron donor is in the cytoplasm while the production ofO2 takes place at the outer surface of the (Fig. 2) . It therefore appears that the portion of the oxidase responsible for latent O2 production is protected by its situation in the membrane vesicle. These findings strongly suggest that the oxidase does not traverse the membrane, but is embedded in it with a portion projecting from only one face. These results were confirmed in experiments with the nonpenetrating sulfbydryl reagent pCMBS. As shown in Table II , overt O2 production is abolished by treatmenit with pCMBS, but latent O2 production is unchanged. This finding strengthens the previous conclusion that the oxidase projects from only one face of the membrane, since results consistent with this idea were obtained with two nonpenetrating reagents havin-g two very different modes of action.
Cohen et al. (17) have shown that phagocytic vesicles Table III shows that almost all the 02-forming activity of phagocytic vesicles was sensitive to trypsin. Triton X-100 had little effect on O2 production by either trypsin-treated or control vesicles, demonstrating that in these preparations all the 02-forming activity was overt, and confirming the homogeneous orientation of the membranes of phagocytic vesicles. These results indicate that the oxidase projects into the cytoplasm from the inner face of the plasma membrane.
It is reasonable to propose that the portion of the oxidase that projects out of the membrane contains the pyridine nucleotide-binding site. Evidence for this was sought by examining the effect of pyridine nucleotides on inactivation by pCMBS. The two reduced The most speculative feature of this model has to do with the locations of the substrate binding sites. The present observations provide no evidence as to this feature, so the locations proposed in the model are based on other considerations. With respect to the pyridine nucleotide binding site, it seems reasonable to postulate that it is on the cytoplasmic extension, since it must be accessible to NADPH, a constituent of the cytoplasm. Evidence concerning the location of the oxygen binding site is provided by the study of Root and Metcalf (10), in which it was shown that°2 produced by intact neutrophils does not pass through the cytoplasm on its way into the extracellular medium. This observation suggests that the oxygen-binding site is located on the intramembranous portion of the oxidase.
Other investigators have published observations that might be construed to indicate that a portion of the oxidase projects from the external face ofthe neutrophil membrane (19) (20) (21) . There are alternative explanations, however, for all these observations. The cytochemical data ofBriggs et al. (19) could be accounted for by postulating that H202 produced within the neutrophil membrane diffuses out to react with an extracellular H202-detecting system. Reports that the respiratory burst is abolished by treating neutrophils with nonpenetrating reagents prior to activation (20, 21) could be explained by postulating damage to the activating mechanism rather than the oxidase itself. The present findings are thus consistent with prior work dealing with the arrangement of the respiratory burst within the plasma membrane of the neutrophil.
